Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 35 Schemes (12.39%)
Foreign Institutions
Held by 49 Foreign Institutions (13.71%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
(Quarterly Results - Mar 2026)
Net Profit:
-33 Million
Pharmaceuticals & Biotechnology
USD 1,007 Million (Small Cap)
NA (Loss Making)
NA
0.00%
-1.38
-999,999.00%
27.35






